Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
about
Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on In Vitro Models for Plant-Derived Compounds.[Efficacy and Toxicity of Metronomic Oral Vinorelbinen in Advanced Non-small Cell Lung Cancer after Failure to Multiple-lines Treatments].Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer
P2860
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@en
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@nl
type
label
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@en
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@nl
prefLabel
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@en
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@nl
P2093
P2860
P356
P1476
Metronomic treatment of advanc ...... vinorelbine - a Phase I trial.
@en
P2093
Achim Rittmeyer
Amanda Tufman
Astrid Borgmeier
Birgit Edlich
Joachim von Pawel
Pierre Ferré
Rudolf Maria Huber
Sylvia Guetz
P2860
P304
P356
10.2147/OTT.S122106
P407
P577
2017-02-21T00:00:00Z